Skip to main content
Clinical Trials/NCT00937144
NCT00937144
Withdrawn
Phase 4

Endothelial Function in Patients With Sickle Cell Anemia Before and After Sildenafil

The Baruch Padeh Medical Center, Poriya1 site in 1 country15 target enrollmentSeptember 2009

Overview

Phase
Phase 4
Intervention
Viagra (Sildenafil)
Conditions
Sickle Cell Anemia
Sponsor
The Baruch Padeh Medical Center, Poriya
Enrollment
15
Locations
1
Primary Endpoint
endothelial function before and after viagra treatment to patients with sickle cell anemia without pulmonary hypertension
Status
Withdrawn
Last Updated
16 years ago

Overview

Brief Summary

The investigators would like to study the endothelial function in sickle cell patients without pulmonary hypertension in an in vivo method during a steady state condition before and after sildenafil treatment for 1 month, and to study the effects of this nitric oxide donor by measuring the Flow Mediated Dilatation, by measuring endothelial progenitor stem cells colonies, and by measuring the effect of therapy on markers of inflammation (cell adhesion molecules and cytokines).

Registry
clinicaltrials.gov
Start Date
September 2009
End Date
February 2010
Last Updated
16 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • patients with sickle cell anemia

Exclusion Criteria

  • patients with sickle cell anemia during acute crisis

Arms & Interventions

viagra

viagra versus placebo will be given to patients with sickle cell anemia

Intervention: Viagra (Sildenafil)

placebo

viagra versus placebo will be given to patients with sickle cell anemia

Intervention: placebo

Outcomes

Primary Outcomes

endothelial function before and after viagra treatment to patients with sickle cell anemia without pulmonary hypertension

Time Frame: January 2009 till January 2011

Study Sites (1)

Loading locations...

Similar Trials